Company Filing History:
12 out of 35 
1 out of 164 
Years Active: 2014-2020
Title: The Innovative Mind of Frank Otto Gombert
Introduction
Frank Otto Gombert, based in Basel, Switzerland, is a prolific inventor with a remarkable collection of 12 patents. His work primarily revolves around the development of peptidomimetics, showcasing his innovative contributions to medical science, particularly in addressing elastase-related diseases and HIV infections.
Latest Patents
One of Frank Otto Gombert's latest patents, titled "Beta-hairpin peptidomimetics as selective elastase inhibitors," focuses on compounds designed to inhibit elastase activity, specifically targeting human neutrophil elastase. These compounds hold potential for preventing infections and diseases associated with elastase activity. Furthermore, Gombert's research extends to peptidomimetics formulated to treat or slow down diseases like cancer and various immunological and pulmonary disorders.
Another significant patent showcases beta-hairpin peptidomimetics that can prevent HIV infections and address conditions influenced by CXCR4 receptor activity. The pharmacological properties of these compounds could aid patients with immunosuppression during apheresis procedures, emphasizing their versatility and clinical importance.
Career Highlights
Frank Otto Gombert's professional journey includes impactful roles at notable institutions such as Polyphor AG and the University of Zurich. His expertise in the field has led to groundbreaking research and advancements in the synthesis of therapeutic agents, especially through innovative mixed solid- and solution phase synthetic strategies.
Collaborations
Throughout his career, Gombert has collaborated with esteemed colleagues, including Daniel Obrecht and Alexander Lederer. These partnerships have fostered a collaborative environment in which innovative ideas flourish, leading to significant advancements in their respective fields.
Conclusion
Frank Otto Gombert embodies the spirit of innovation, with a focus on creating solutions that address critical health issues. His contributions through various patents reflect a commitment to enhancing medical therapies and improving patient outcomes. As he continues his work, the potential impact of his inventions promises to be far-reaching and transformative in the realms of medicine and biotechnology.